[go: up one dir, main page]

BR0113731A - Comprimidos contendo epinastina produzidos por compressão direta - Google Patents

Comprimidos contendo epinastina produzidos por compressão direta

Info

Publication number
BR0113731A
BR0113731A BR0113731-0A BR0113731A BR0113731A BR 0113731 A BR0113731 A BR 0113731A BR 0113731 A BR0113731 A BR 0113731A BR 0113731 A BR0113731 A BR 0113731A
Authority
BR
Brazil
Prior art keywords
epinastine
direct compression
containing tablets
tablets produced
produced
Prior art date
Application number
BR0113731-0A
Other languages
English (en)
Inventor
Toshimitsu Ohki
Kazutoshi Yokoyama
Wakuko Yamaguchi
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR0113731A publication Critical patent/BR0113731A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"COMPRIMIDOS CONTENDO EPINASTINA PRODUZIDOS POR COMPRESSãO DIRETA". A invenção refere-se a um comprimido produzido por um processo de compressão direta compreendendo Epinastina como agente com uma estabilidade a armazenamento aperfeiçoada.
BR0113731-0A 2000-09-08 2001-09-04 Comprimidos contendo epinastina produzidos por compressão direta BR0113731A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000315849A JP2002087963A (ja) 2000-09-08 2000-09-08 直接打錠により製造されたエピナスチン含有錠剤
PCT/EP2001/010139 WO2002020018A1 (en) 2000-09-08 2001-09-04 Tablets containing epinastine manufactured by direct compression

Publications (1)

Publication Number Publication Date
BR0113731A true BR0113731A (pt) 2003-07-29

Family

ID=18794888

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113731-0A BR0113731A (pt) 2000-09-08 2001-09-04 Comprimidos contendo epinastina produzidos por compressão direta

Country Status (6)

Country Link
JP (1) JP2002087963A (pt)
AU (1) AU2001291820A1 (pt)
BR (1) BR0113731A (pt)
EC (1) ECSP034501A (pt)
MX (1) MXPA03002013A (pt)
WO (1) WO2002020018A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2494065A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
JP5162141B2 (ja) * 2007-02-20 2013-03-13 エスエス製薬株式会社 フィルムコーティング用組成物
JP5291324B2 (ja) * 2007-11-01 2013-09-18 沢井製薬株式会社 口腔内崩壊錠
JP5806490B2 (ja) * 2011-03-31 2015-11-10 エスエス製薬株式会社 フィルムコーティング用組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
CN1283115A (zh) * 1997-12-23 2001-02-07 先灵公司 用于治疗呼吸道和皮肤病的含有至少一种白三烯拮抗剂和至少一种抗组胺药的组合物
EP1000623A1 (en) * 1998-09-29 2000-05-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Use of epinastine as antitussivum
JP4016128B2 (ja) * 1999-09-09 2007-12-05 東和薬品株式会社 耐光性塩酸エピナスチンフィルムコート錠

Also Published As

Publication number Publication date
WO2002020018A1 (en) 2002-03-14
ECSP034501A (es) 2003-04-25
AU2001291820A1 (en) 2002-03-22
MXPA03002013A (es) 2003-07-24
JP2002087963A (ja) 2002-03-27
WO2002020018A8 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
BR122018068298B8 (pt) processo para a produção de um comprimido seguro contra abuso termo-moldado por extrusão sem descoramento
BR0105899A (pt) Agente cosmético pulverulento e processo para a sua preparação
BR0207726A (pt) Sais farmacêuticos
SV1999000048A (es) Uso de dihidropiriminas como medicamento y nuevas sustancias ref. lea 32 791-sv
BR0215392A (pt) Composições farmacêuticas compreendendo um inibidor de fosfodiesterase multifuncional e um inibidor de absorção de adenosina, bem como uso das mesmas
BR0308211A (pt) Cumarinas úteis como biomarcadores
BR0112070A (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas
MX9303376A (es) Utilizacion de metilhidroxietil- o metilhidroxipropil-(eteres de celulosa)carboximetilados.
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
ES2175825T3 (es) Antitraspirante con dibencilidensorbitol.
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
PT1389213E (pt) Formulacoes de 3,7-diazabiciclo 3,3,1¿ como compostos antiarritmicos
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
BR0012553A (pt) Pastilhas contendo ambroxol
BR0113731A (pt) Comprimidos contendo epinastina produzidos por compressão direta
ECSP055803A (es) Ésteres de ácido carbámico con actividad anticolinérgica
UY26494A1 (es) " estabilización de vino"
BR0116077A (pt) Micropartìculas com perfil de liberação aperfeiçoado e processos para produção das mesmas
ITRM950143V0 (it) Fermo per evitare la dilatazione di contenitori comprimibili, dopo la loro compressione.
DE59805352D1 (de) Wasch- und reinigungsmittelformkörper mit verbesserten zerfallseigenschaften
HRP20050611B1 (hr) Kombinacijski lijek
BR0208553A (pt) Agente de revestimento aquoso transparente com pó de vidro
HN2000000090A (es) Sal difosfato de un derivado de 4sustituido-9-desoxo-9a-aza-9a-homoeritromicina y su composicion farmaceutica.
ES2196171T3 (es) Agentes antitumorales de tioxantenona liofilizada.

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A E 8A ANUIDADES

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2021 DE 29/09/2009.